Ghodsieh Zamani1, Sajjad Ataei Azimi2, Ali Aminizadeh1, Elham Shams Abadi2, Mostafa Kamandi2, Hasan Mortazi2, Somayeh Shariat2, Mojtaba Abrishami3,4. 1. Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 2. Department of Hematology-Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 3. Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. mojtaba_abrishami@yahoo.com. 4. Eye Research Center, Khatam-al-Anbia Eye Hospital, Qarani Blvd, Mashhad, 9195965919, Iran. mojtaba_abrishami@yahoo.com.
Abstract
PURPOSE: Acute macular neuroretinopathy (AMN) is a visual-deteriorating rare clinical entity with an uncertain etiology. We aimed to report a case of AMN and underlying disease of acute myeloid leukemia (AML). CASE PRESENTATION: A thirty-five-year-old female patient with bone marrow biopsy confirmed AML, and bicytopenia, under chemotherapy, complained of sudden paracentral visual field defect in her right eye was referred. Visual acuity was 20/20 in both eyes. Posterior segment evaluation revealed multiple Roth's spots. Optical coherence tomography (OCT) demonstrated hyper-reflectivity band, in the outer nuclear layer and outer plexiform layer, nasal to the fovea of the right eye, and hyperreflective patch in outer retina segmentation en-face OCT, suggestive of the diagnosis of AMN. Nine days after AMN diagnosis, dyspnea, malaise, and cough was initiated. Ground glass opacities in lung CT scan, beside reverse transcription polymerase chain reaction of severe acute respiratory syndrome coronavirus-2, was conclusive of coronavirus disease 2019 (COVID-19). The patient deceased after 6 days. CONCLUSION: We report a rare case of AMN following AML. Our findings support the role of ischemia in the outer retina, of which AML may contributed to the pathophysiological process. The patient has deceased less than 2 weeks from AMN initiation.
PURPOSE:Acute macular neuroretinopathy (AMN) is a visual-deteriorating rare clinical entity with an uncertain etiology. We aimed to report a case of AMN and underlying disease of acute myeloid leukemia (AML). CASE PRESENTATION: A thirty-five-year-old female patient with bone marrow biopsy confirmed AML, and bicytopenia, under chemotherapy, complained of sudden paracentral visual field defect in her right eye was referred. Visual acuity was 20/20 in both eyes. Posterior segment evaluation revealed multiple Roth's spots. Optical coherence tomography (OCT) demonstrated hyper-reflectivity band, in the outer nuclear layer and outer plexiform layer, nasal to the fovea of the right eye, and hyperreflective patch in outer retina segmentation en-face OCT, suggestive of the diagnosis of AMN. Nine days after AMN diagnosis, dyspnea, malaise, and cough was initiated. Ground glass opacities in lung CT scan, beside reverse transcription polymerase chain reaction of severe acute respiratory syndrome coronavirus-2, was conclusive of coronavirus disease 2019 (COVID-19). The patient deceased after 6 days. CONCLUSION: We report a rare case of AMN following AML. Our findings support the role of ischemia in the outer retina, of which AML may contributed to the pathophysiological process. The patient has deceased less than 2 weeks from AMN initiation.
Authors: Imran Ashfaq; Maria Vrahimi; Sheila Waugh; Taha Soomro; Michael E Grinton; Andrew C Browning Journal: Ocul Immunol Inflamm Date: 2019-11-07 Impact factor: 3.070
Authors: Maria Casagrande; Antonia Fitzek; Klaus Püschel; Ganna Aleshcheva; Heinz-Peter Schultheiss; Laura Berneking; Martin S Spitzer; Maximilian Schultheiss Journal: Ocul Immunol Inflamm Date: 2020-05-29 Impact factor: 3.070
Authors: Paula M Marinho; Allexya A A Marcos; André C Romano; Heloisa Nascimento; Rubens Belfort Journal: Lancet Date: 2020-05-12 Impact factor: 79.321
Authors: Russel H Dinh; Edmund Tsui; Matthew S Wieder; Alexander Barash; Michael M Park; Ehsan Rahimy; Prithvi Mruthyunjaya; Louise J Lu; Suzanne M Michalak; Rohan J Shah; David Sierpina; Timothy W Winter; Ryan A Shields; Eduardo Uchiyama; Gregory D Lee; Rahul Komati; Eric Lee; Sundeep K Kasi; Brian K Do Journal: Ophthalmol Retina Date: 2022-10-07